EFIGENIO BAUTISTA: Open Payments
NPI 1427032705 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 6 payments from 6 companies in 2025. Trend: 2023 $828 · 2024 $547 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
Products named: COBENFY, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR, SUBLOCADE, ARISTADA.
Industry payments across MD — which companies pay providers there.
